PPARs: Interference with Warburg’ Effect and Clinical Anticancer Trials
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PPARs: Interference with Warburg’ Effect and Clinical Anticancer Trials
Authors
Keywords
-
Journal
PPAR Research
Volume 2012, Issue -, Pages 1-23
Publisher
Hindawi Limited
Online
2012-05-09
DOI
10.1155/2012/304760
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the Tumor Stroma with Peroxisome Proliferator Activated Receptor (PPAR) Agonists
- (2012) Annika Bundscherer et al. Anti-Cancer Agents in Medicinal Chemistry
- Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus
- (2012) Laia Salvadó et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Warburg Meets Autophagy: Cancer-Associated Fibroblasts Accelerate Tumor Growth and Metastasis via Oxidative Stress, Mitophagy, and Aerobic Glycolysis
- (2011) Stephanos Pavlides et al. ANTIOXIDANTS & REDOX SIGNALING
- Vascular PPARδ Protects Against Stroke-Induced Brain Injury
- (2011) Ke-Jie Yin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Autophagy modulation for cancer therapy
- (2011) Zhineng J. Yang et al. CANCER BIOLOGY & THERAPY
- Drug therapy of cancer
- (2011) Curt Peterson EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Stromal–epithelial metabolic coupling in cancer: Integrating autophagy and metabolism in the tumor microenvironment
- (2011) Ubaldo E. Martinez-Outschoorn et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Growing tumor vessels: More than one way to skin a cat – Implications for angiogenesis targeted cancer therapies
- (2011) Rodrigo Leite de Oliveira et al. MOLECULAR ASPECTS OF MEDICINE
- Autophagy as a target for anticancer therapy
- (2011) Filip Janku et al. Nature Reviews Clinical Oncology
- Targeting autophagy during cancer therapy to improve clinical outcomes
- (2011) Jean M. Mulcahy Levy et al. PHARMACOLOGY & THERAPEUTICS
- Targeting Vascular NADPH Oxidase 1 Blocks Tumor Angiogenesis through a PPARα Mediated Mechanism
- (2011) Sarah Garrido-Urbani et al. PLoS One
- Autophagic pathways as new targets for cancer drug development
- (2010) Bo Liu et al. ACTA PHARMACOLOGICA SINICA
- PPARδ agonists suppress angiogenesis in a VEGFR2-dependent manner
- (2010) Markus Meissner et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy
- (2010) Michael Dewaele et al. Autophagy
- Troglitazone-mediated sensitization to TRAIL-induced apoptosis is regulated by proteasome-dependent degradation of FLIP and ERK1/2-dependent phosphorylation of BAD
- (2010) Kerstin Grund et al. CANCER BIOLOGY & THERAPY
- Role of Peroxisome Proliferator-Activated Receptor-γ and Its Coactivator DRIP205 in Cellular Responses to CDDO (RTA-401) in Acute Myelogenous Leukemia
- (2010) Twee Tsao et al. CANCER RESEARCH
- An RNA Interference Screen Identifies Metabolic Regulators NR1D1 and PBP as Novel Survival Factors for Breast Cancer Cells with the ERBB2 Signature
- (2010) A. Kourtidis et al. CANCER RESEARCH
- Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the “reverse Warburg effect”: A transcriptional informatics analysis with validation
- (2010) Stephanos Pavlides et al. CELL CYCLE
- Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth
- (2010) T Botton et al. CELL DEATH AND DIFFERENTIATION
- Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
- (2010) A. Vazquez-Martin et al. CELL PROLIFERATION
- The mTOR Pathway: A New Target in Cancer Therapy
- (2010) L. Ciuffreda et al. CURRENT CANCER DRUG TARGETS
- The Anti-tumorigenic Properties of Peroxisomal Proliferator-activated Receptor α Are Arachidonic Acid Epoxygenase-mediated
- (2010) Ambra Pozzi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Natural Angiogenesis Inhibitor Signals through Erk5 Activation of Peroxisome Proliferator-activated Receptor γ (PPARγ)
- (2010) Dauren Biyashev et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolic alterations and targeted therapies in prostate cancer
- (2010) Richard Flavin et al. JOURNAL OF PATHOLOGY
- ACTIVATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-β/δ ATTENUATES MYOCARDIAL ISCHEMIA/REPERFUSION INJURY IN THE RAT
- (2010) Amar Kapoor et al. SHOCK
- PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid -Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease
- (2010) James P. Hardwick et al. PPAR Research
- Peroxisome proliferator-activated receptor γ and colorectal cancer
- (2010) Yun Dai World Journal of Gastrointestinal Oncology
- Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells
- (2009) Thomas W. Grunt et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activation of PPARδ up-regulates fatty acid oxidation and energy uncoupling genes of mitochondria and reduces palmitate-induced apoptosis in pancreatic β-cells
- (2009) Jun Wan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mouse carnitine–acylcarnitine translocase (CACT) is transcriptionally regulated by PPARα and PPARδ in liver cells
- (2009) Anke Gutgesell et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: Molecular mechanisms and therapeutic perspectives
- (2009) Javier A. Menendez BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Novel Agents on the Horizon for Cancer Therapy
- (2009) W. W. Ma et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Randomized Double-Blind Phase II Trial Comparing Gemcitabine Plus LY293111 Versus Gemcitabine Plus Placebo in Advanced Adenocarcinoma of the Pancreas
- (2009) Muhammad Wasif Saif et al. CANCER JOURNAL
- PPARγ agonists inhibit angiogenesis by suppressing PKCα- and CREB-mediated COX-2 expression in the human endothelium
- (2009) Egeria Scoditti et al. CARDIOVASCULAR RESEARCH
- Peroxisome proliferator-activated receptor β stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin
- (2009) Nicole Wagner et al. CARDIOVASCULAR RESEARCH
- MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
- (2009) C. V. Dang et al. CLINICAL CANCER RESEARCH
- Nuclear receptors in head and neck cancer: current knowledge and perspectives
- (2009) Andrea Schweitzer et al. INTERNATIONAL JOURNAL OF CANCER
- Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction
- (2009) Ismael Samudio et al. JOURNAL OF CLINICAL INVESTIGATION
- In Vitro and In Vivo Anti-Melanoma Effects of Ciglitazone
- (2009) Thomas Botton et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Metabolic Syndrome and Cancer
- (2009) Pooja Pothiwala et al. Metabolic Syndrome and Related Disorders
- Influence of pharmacological PPARα activators on carnitine homeostasis in proliferating and non-proliferating species
- (2009) Robert Ringseis et al. PHARMACOLOGICAL RESEARCH
- Peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) acts as regulator of metabolism linked to multiple cellular functions
- (2009) Kay-Dietrich Wagner et al. PHARMACOLOGY & THERAPEUTICS
- PPARs: A Double-Edged Sword in Cancer Therapy?
- (2009) Dipak Panigrahy et al. PPAR Research
- Current Understanding of the Role of PPARγin Gastrointestinal Cancers
- (2009) Bing Zou et al. PPAR Research
- Pharmacological activation of PPARβ promotes rapid and calcineurin-dependent fiber remodeling and angiogenesis in mouse skeletal muscle
- (2008) Céline Gaudel et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis
- (2008) Ahmad Aljada et al. ANGIOGENESIS
- Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase
- (2008) Varda Shoshan-Barmatz et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?
- (2008) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Cancer Cell Metabolism: Warburg and Beyond
- (2008) Peggy P. Hsu et al. CELL
- Roles of p53, Myc and HIF-1 in Regulating Glycolysis — the Seventh Hallmark of Cancer
- (2008) S. J. Yeung et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Regulation of gene expression by hypoxia: Integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element
- (2008) Stefan Kaluz et al. CLINICA CHIMICA ACTA
- PPAR Modulators and PPAR Pan Agonists for Metabolic Diseases: The Next Generation of Drugs Targeting Peroxisome Proliferator-Activated Receptors?
- (2008) P. Feldman et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The Simultaneous Expression of Peroxisome Proliferator-Activated Receptor Delta and Cyclooxygenase-2 May Enhance Angiogenesis and Tumor Venous Invasion in Tissues of Colorectal Cancers
- (2008) Masahiro Yoshinaga et al. DIGESTIVE DISEASES AND SCIENCES
- Clofibrate treatment up-regulates novel organic cation transporter (OCTN)-2 in tissues of pigs as a model of non-proliferating species
- (2008) Robert Ringseis et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Is cancer a disease of abnormal cellular metabolism? New angles on an old idea
- (2008) Ralph J Deberardinis GENETICS IN MEDICINE
- Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir
- (2008) Emma Hernlund et al. INTERNATIONAL JOURNAL OF CANCER
- Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment’s roles together with hexokinase-2 in the “Warburg effect” in cancer
- (2008) Peter L. Pedersen JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- The tyrosine kinase receptor HER2 (erbB-2): From oncogenesis to adipogenesis
- (2008) Alejandro Vazquez-Martin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- In Vivo Activation of Peroxisome Proliferator-Activated Receptor- Protects the Heart from Ischemia/Reperfusion Injury in Zucker Fatty Rats
- (2008) T.-L. Yue et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells
- (2008) Yekaterina Y Zaytseva et al. Molecular Cancer
- Disruption of the hexokinase–VDAC complex for tumor therapy
- (2008) L Galluzzi et al. ONCOGENE
- PPAR agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition
- (2008) D. Panigrahy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PPARδ is pro-tumorigenic in a mouse model of COX-2-induced mammary cancer
- (2008) Mallika Ghosh et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Rosiglitazone Effect on Radioiodine Uptake in Thyroid Carcinoma Patients with High Thyroglobulin but Negative Total Body Scan: A Correlation with the Expression of Peroxisome Proliferator–Activated Receptor-Gamma
- (2008) Supatporn Tepmongkol et al. THYROID
- Peroxisome Proliferator-Activated Receptor-γLigands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer
- (2008) Costas Giaginis et al. PPAR Research
- NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδContribute to Colon Carcinogenesis?
- (2008) Gerardo G. Mackenzie et al. PPAR Research
- Clinical Use of PPARγLigands in Cancer
- (2008) Jennifer L. Hatton et al. PPAR Research
- A Role for PPARβ/δin Tumor Stroma and Tumorigenesis
- (2008) Rolf Müller et al. PPAR Research
- Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-γLigands in Lung Cancer
- (2008) Raphael A. Nemenoff et al. PPAR Research
- To Live or to Die: Prosurvival Activity of PPARγin Cancers
- (2008) Y. Lynn Wang et al. PPAR Research
- The Role of PPAR in Hepatocellular Carcinoma
- (2008) Ivan Borbath et al. PPAR Research
- The Roles of Dietary PPAR Ligands for Metastasis in Colorectal Cancer
- (2008) Hiroki Kuniyasu PPAR Research
- PPARγand Apoptosis in Cancer
- (2008) Heath A. Elrod et al. PPAR Research
- PPARs Mediate Lipid Signaling in Inflammation and Cancer
- (2008) Liliane Michalik et al. PPAR Research
- A Role for the PPARγin Cancer Therapy
- (2008) Moray J. Campbell et al. PPAR Research
- PPARγand MEK Interactions in Cancer
- (2008) Elke Burgermeister et al. PPAR Research
- The Role of PPARs in Cancer
- (2008) Keisuke Tachibana et al. PPAR Research
- Anticancer Properties of PPARα-Effects on Cellular Metabolism and Inflammation
- (2008) Maja Grabacka et al. PPAR Research
- Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
- (2008) Roberto Scatena et al. PPAR Research
- Synergistic Effects of PPARγLigands and Retinoids in Cancer Treatment
- (2008) Masahito Shimizu et al. PPAR Research
- 1,1-bis(3′-indolyl)-1-(p-substituted phenyl)methanes decrease mitochondrial membrane potential and induce apoptosis in endometrial and other cancer cell lines
- (2007) Jun Hong et al. MOLECULAR CARCINOGENESIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now